Lamivudine and rapid regeneration of the atrophic liver in decompensated cirrhosis due to hepatitis B.
Saito
Takafumi
T
Shinzawa
Haruhide
H
Watanabe
Hisayoshi
H
Sugahara
Kazuhiko
K
Okumoto
Kazuo
K
Togashi
Hitoshi
H
Kawata
Sumio
S
D001284:Atrophy / Q000473:pathology; D001707:Biopsy, Needle; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000000981:diagnostic imaging; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage*; D008103:Liver Cirrhosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology*; D008111:Liver Function Tests; D008115:Liver Regeneration / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D012720:Severity of Illness Index; D015899:Tomography, Emission-Computed, Single-Photon; D016896:Treatment Outcome
D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine